secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zai Lab Ltd (ZLAB)
CIK:        0001704292
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0001628280-24-027668
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zai Lab CMO Dr. Harald Reinhart to retire; Dr. Rafael Amado to lead all Global R&D
--------------------------------------------------------------------------------

- Dr. Harald Reinhart, President, Head of Global Development (NSAiID), retiring effective June 30, 2024.
- Reinhart will remain as a senior advisor; no disagreements led to his retirement.
- Dr. Rafael Amado expands role to President, Head of Global R&D upon Reinhart's retirement.
- Amado previously President of Global Oncology R&D; now oversees all therapy areas.
- CEO Samantha Du noted Reinhart built strong NSAiID team for continued growth under Amado.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704292/000162828024027668/0001628280-24-027668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704292/000162828024027668/zlab-20240611.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-027668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer